The UK government has reached a new five-year medicines pricing deal with the pharma industry to replace the almost 60-year-old Pharmaceutical Price Regulation Scheme (PPRS).
The UK’s pharma trade body, the Association of the British Pharmaceutical Industry (ABPI), has signed a five-year partnership that aims to increase the use of novel medical technology acros
The UK pharma and biotech industries have warned that clarity on Brexit arrangements for medicines is needed urgently - but no deal is in sight just 13 months ahead of its official departur
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.